Dr. Julie Parsonnet, MD

Dr. Parsonnet practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Parsonnet's NPI, 1083771646, was assigned on January 3, 2007. Dr. Parsonnet graduated from Weill Cornell Medicine in 1983. Dr. Parsonnet holds California license G67987.

Dr. Parsonnet's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Parsonnet's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Parsonnet to 1 more hospital and 1 medical group, each named with a free account. Dr. Parsonnet's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parsonnet practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Parsonnet's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Parsonnet is board certified in infectious disease by the American Board of Internal Medicine. Dr. Parsonnet is licensed in California.

Dmand AI lists acute skin infection, endocarditis, joint or bone infection and UTI among the conditions Dr. Parsonnet treats.

CMS data shows 66 Medicare services from Dr. Parsonnet across 2 procedure codes in 2024, all of them office visits, for 71 Medicare patients. Medicare paid $9,459 for them. Every service was in an office.

CMS counts 71 Medicare patients who saw Dr. Parsonnet in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parsonnet's median patient age at 54, with 48% women.

In 2024, Dr. Parsonnet wrote 116 Medicare Part D claims for 27 patients. 97% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $392 in total drug cost. In 2023, CMS named 49 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Parsonnet for performance year 2024, reported as part of a group. Dr. Parsonnet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parsonnet as offering telehealth.

Dmand AI links 172 papers to Dr. Parsonnet, published from 2002 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Helicobacter pylori, Helicobacter Infections and Stomach Neoplasms. Dr. Parsonnet has published most often in Cancer Epidemiol Biomarkers Prev. Dr. Parsonnet's most frequent co-authors are Glenn Matthew Chertow, MD, Shuchi Md Anand, MD and Geoffrey Allan Block, MD.

Dmand AI links Dr. Parsonnet to 7 clinical trials, 2 of them phase 2 studies. Conditions studied include COVID-19, Pneumonia, Viral and Achlorhydria. Stanford University sponsors the most, 7.

Dmand AI lists 2 awards for Dr. Parsonnet, most recently Elected Member in 2019.

Dr. Parsonnet graduated from Weill Cornell Medicine in 1983.

Dr. Parsonnet is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.